Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Preparing word cloud

×

Cellosaurus is database indexing available cell lines from various collections: American Type Culture Collection (ATCC), Bioresource Collection and Research Center, Taiwan (BCRC), Banco de Células do Rio de Janeiro (BCRJ), CellBank Australia (CBA), Collection of Cell Lines in Veterinary Medicine (CCLV), Cell Lines Service (CLS), Coriell, Drosophila Genomics Resource Center (DGRC), Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), European Bank for induced pluripotent Stem Cells (EBiSC), European Collection of Authenticated Cell Cultures (ECACC), Interlab Cell Line Collection (ICLC), Institute for Fermentation Osaka (IFO), Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) biobank, Japanese Collection of Research Bioresources (JCRB) Cell Bank, Kunming Cell Bank of Type Culture Collection (KCB), Korean Cell Line Bank (KCLB), Millipore, National Cell Bank of Iran (NCBI_Iran), National Cancer Institute - Developmental Therapeutics Program (NCI-DTP), NINDS Human Cell and Data Repository (NHCDR), NIH AIDS Reagent Program (NIH-ARP), NISES, RIKEN Bioresource Center Cell Bank (RCB), Royan Stem Cell Bank (RSCB), Tick Cell Biobank (TCB), Tohoku University cell line catalog (TKG), and Ximbio.

Suggested Search Criteria

Enter extra filters to help narrow your search

Search

Type in a keyword to search
Reset search
Filter by records added date

See new records

Options

Recent searches

Snippet view Table view

Can't find the RRID you're searching for? X
Click the to add this resource to an Authentication Report or Collection

14 Results - per page

Show More Columns | Download 14 Result(s)

Name

Sort Ascending

Sort Descending

 Proper Citation

Sort Ascending

Sort Descending

 Organism

Sort Ascending

Sort Descending

 Disease

Sort Ascending

Sort Descending

 Comments
Defining Citation

Sort Ascending

Sort Descending

 Category

Sort Ascending

Sort Descending

 Sex

Sort Ascending

Sort Descending

 Synonyms

Sort Ascending

Sort Descending

 Vendor

Sort Ascending

Sort Descending

 Catalog Number
Cross References

Sort Ascending

Sort Descending

 Hierarchy

Sort Ascending

Sort Descending

 Originate from Same Individual

Sort Ascending

Sort Descending

 ID
Record Last Update

Sort Ascending

Sort Descending

 Mentions Count

Sort Ascending

Sort Descending
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		NCBI_Iran Cat# C144, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 NCBI_Iran C144 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:22 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		TKG Cat# TKG 0403, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 TKG TKG 0403 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		RCB Cat# RCB1889, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 RCB RCB1889 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		AddexBio Cat# C0050001/4983, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 AddexBio C0050001/4983 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:22 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		CLS Cat# 300397, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 CLS 300397 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:42:11 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		IZSLER Cat# BS TCL 23, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 IZSLER BS TCL 23 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		ATCC Cat# CCL-23, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 ATCC CCL-23 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		ECACC Cat# 86030501, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 ECACC 86030501 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:22 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		KCLB Cat# 10023, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 KCLB 10023 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		CCLV Cat# CCLV-RIE 0141, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 CCLV CCLV-RIE 0141 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		BCRC Cat# 60042, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 BCRC 60042 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		BCRJ Cat# 0101, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 BCRJ 0101 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:22 2889
HEp-2
 
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued 		CCTCC Cat# GDC0004, RRID:CVCL_1906 Homo sapiens (Human) Human papillomavirus-related endocervical adenocarcinoma Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958 		Cancer cell line Female Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 CCTCC GDC0004 BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
FANTOM5_SSTAR:11890-125D9,
FANTOM5_SSTAR:11891-125E1,
FANTOM5_SSTAR:11892-125E2,
FANTOM5_SSTAR:11894-125E4,
FANTOM5_SSTAR:11895-125E5,
FANTOM5_SSTAR:11896-125E6,
FANTOM5_SSTAR:11898-125E8,
FANTOM5_SSTAR:11899-125E9,
FANTOM5_SSTAR:11900-125F1,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737		 cvcl_0030 CVCL_1906 2026-08-01 05:13:20 2889

Can't find your Cell Line?

We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.

If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.

Can't find the RRID you're searching for? X
X

  1. Neuroscience Information Framework Resources

    Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search

  5. Collections

    If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  6. Facets

    Here are the facets that you can filter the data by.

  7. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

About

Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web.  We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.

Recent News Entries

Recommendations for repositories and scientific gateways from a neuroscience perspective

NEURON course at the CNS meeting

Neuron Course this year has just been announced!

Contact Us

About SciCrunch | Privacy Policy | Terms of Service

SciCrunch